Clint Tomlinson | executive |
Christopher Missling | executive |
Sandra Boenisch | executive |
Tom Bishop | analyst |
Soumit Roy | analyst |
Good morning, and welcome to the Anavex Life Sciences Fiscal 2024 Third Quarter Conference Call. My name is Clint Tomlinson, and I will be your host for today's call. [Operator Instructions] With us today is Dr. Christopher Missling, President and Chief Executive Officer; and Sandra Boenisch Principal Financial Officer.
Before we begin, please note that during this conference call, the company will make some projections and forward-looking statements.